|
Download
PDF
|
Pipeline/Commercial Insight:
Molecular Targeted Cancer Therapies - More drugs on the market,
more targets in the pipeline
Cancer treatment continues to embrace the inclusion of molecular targeted therapies (MTT) into standard treatment regimens. With an increasing number of candidates gaining approval, and with a dynamic developmental pipeline, further clinical, commercial and strategic challenges are continuing to emerge.
View
Table Of Contents >
|
